KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Equity Ratio: 2009-2025

Historic Equity Ratio for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Sep 2025 value amounting to 0.70.

  • Vertex Pharmaceuticals' Equity Ratio fell 0.89% to 0.70 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.70, marking a year-over-year decrease of 0.89%. This contributed to the annual value of 0.73 for FY2024, which is 5.84% down from last year.
  • Vertex Pharmaceuticals' Equity Ratio amounted to 0.70 in Q3 2025, which was down 2.51% from 0.71 recorded in Q2 2025.
  • Vertex Pharmaceuticals' Equity Ratio's 5-year high stood at 0.78 during Q3 2022, with a 5-year trough of 0.70 in Q3 2025.
  • In the last 3 years, Vertex Pharmaceuticals' Equity Ratio had a median value of 0.73 in 2024 and averaged 0.74.
  • Per our database at Business Quant, Vertex Pharmaceuticals' Equity Ratio rose by 4.95% in 2021 and then declined by 7.53% in 2024.
  • Vertex Pharmaceuticals' Equity Ratio (Quarterly) stood at 0.75 in 2021, then climbed by 1.94% to 0.77 in 2022, then grew by 0.90% to 0.77 in 2023, then fell by 5.84% to 0.73 in 2024, then decreased by 0.89% to 0.70 in 2025.
  • Its last three reported values are 0.70 in Q3 2025, 0.71 for Q2 2025, and 0.72 during Q1 2025.